Cadila gets USFDA nod for Gatifloxacin

Cadila Healthcare Ltd has received tentative approval from US FDA to market its antibiotic, Gatifloxacin tablets, 200 mg and 400 mg, in the US market. The company would market the broad-spectrum......

Drug prices dip 70% from entry levels

The Rs 19,000 crore (Rs 190 billion) domestic pharmaceutical industry, which comprises over 13,000 brands, has witnessed a sharp drop in drug prices over a period of time.The trend is pertinent in......

Lyka in talks with MNCs for contract manufacturing

The Rs 250 crore (Rs 2.5 billion) Lyka Group is in talks with various multinational companies for contract manufacturing of active pharmaceutical ingredients in cardiovascular and diabetes......